• Eltanexor Modulates Wnt/β-Catenin in CRC

  2026-09-05

  This preclinical study identifies XPO1 inhibition by Eltanexor (KPT-8602) as a potential chemopreventive strategy for colorectal cancer, linking nuclear export blockade to FoxO3a retention, reduced Wnt/β-catenin activity, and lower COX-2 expression. Its combination of cell, organoid, and Apcmin/+ mouse models provides a mechanistic and translational framework for evaluating nuclear export inhibition in genetically predisposed CRC.

• KR-12 Workflow for Antimicrobial Research

  2026-09-04

  KR-12 is a compact LL-37 fragment for connecting membrane-disruption, biofilm, endotoxin, and host-response assays in one experimental workflow. This guide covers TFA-salt handling, concentration planning, assay design, optimization, and practical interpretation of strain-specific activity.

• Kozak Libraries Tune Transgene Expression at Scale

  2026-09-04

  Shukla and colleagues developed a pooled Kozak sequence library that links translation-initiation sequence variation to calibrated protein abundance in mammalian cells. The approach provides an approximately 100-fold expression range and enables functional testing of how transgene abundance interacts with coding variation, including ACE2-mediated viral entry and STIM1 activity.

• NHS-Biotin: Mechanism and Protein Labeling

  2026-09-03

  NHS-Biotin, also called N-hydroxysuccinimido biotin, is an amine-reactive reagent for stable biotinylation of antibodies, proteins, and other primary amine-containing biomolecules. Its short 13.5 Å spacer, organic-solvent handling, and streptavidin-compatible label support controlled detection and purification workflows.

• Veratridine Workflows for Sodium Channel Assays

  2026-09-03

  Veratridine provides a direct, persistent depolarization challenge for sodium channel dynamics research, blocker screening, and excitotoxicity studies. Its proposed use in chamber-specific cardiomyocytes adds a differentiated route to compare right- and left-ventricular electrical phenotypes while preserving clear experimental boundaries.

• Gly-Gly-Phe-Gly (GGFG) Lab Workflow Guide

  2026-09-02

  This scenario-based guide explains how Gly-Gly-Phe-Gly (GGFG), SKU C8670, can be incorporated into bioconjugation workflows without confusing linker effects with payload-driven changes in cell viability or cytotoxicity. It covers assay controls, peptide handling, vendor evaluation, and interpretation of panobinostat-related leukemia data.

• Concanamycin A and the Acidification–Autophagy Axis

  2026-09-02

  Concanamycin A is more than a nanomolar acidification probe: it is a causal perturbation tool for connecting V-ATPase activity with trafficking, autophagy, apoptosis, and tumor invasion. This article frames how translational researchers can use it without confusing lysosomal blockade with increased autophagic flux.

• ASB3-Mediated MAVS Degradation in Antiviral Immunity

  2026-09-01

  The 2024 Cell Death & Differentiation study identifies ASB3 as an inducible E3 ligase that suppresses antiviral innate immunity by directing MAVS toward K48-linked ubiquitination and proteasomal degradation. Its combined molecular, infection, and animal data connect ASB3 activity to weaker TBK1–IRF3 signaling, reduced type I interferon responses, and greater influenza susceptibility.

• Trypsin Workflows for Proteomics and Cell Research

  2026-09-01

  Trypsin is more than a routine protein digestion enzyme: controlled exposure can support cell handling, proteomics, membrane-fusion assays, and cartilage biology workflows. This practical guide connects Trypsin BA5744 with the SMAD3–miRNA-140–ADAMTS-5 osteoarthritis model while emphasizing controls, timing, and troubleshooting.

• CA-074 Me: Mapping Lysosomal Death Decisions

  2026-08-31

  CA-074 Me is a potent cathepsin B inhibitor for testing how lysosomal membrane permeabilization shapes necroptosis and related cell-death outcomes. This article presents a temporally resolved assay strategy that separates lysosomal protease release from downstream plasma membrane rupture.

• Capsaicin Workflows for TRPV1 and KDM1A Research

  2026-08-30

  Capsaicin supports two distinct experimental strategies: controlled TRPV1 ion channel activation in sensory models and mechanistic KDM1A/LSD1 inhibition in gastric cancer studies. This guide turns those complementary activities into practical workflows with dose-selection, assay, controls, and troubleshooting guidance.

• Deep Learning for Sweetpotato Virus Detection

  2026-08-29

  Ding et al. developed a DeepLabV3+ semantic-segmentation model with Attention Pyramid Fusion to identify sweetpotato virus disease lesions in field images. The approach achieved high performance on its primary test set but showed a substantial accuracy decrease on a second dataset, highlighting both the value of targeted augmentation and the continuing challenge of deployment across imaging conditions.

• Merimepodib (VX-497): IMPDH Workflow Guide

  2026-08-29

  Merimepodib (VX-497) connects guanine-nucleotide depletion with practical assays for viral replication, lymphocyte proliferation, and cancer biology. This guide translates recent PEDV findings into controlled workflows, formulation choices, rescue experiments, and troubleshooting strategies.

• Hepatic sEH–Nrf2 Signaling in Osteoporosis

  2026-08-28

  The reference study identifies a liver–bone axis in which hepatic soluble epoxide hydrolase alters circulating epoxide metabolites and inflammatory signals, suppressing Nrf2–ARE activity during osteoclastogenesis. Its combination of clinical samples, an ovariectomy mouse model, liver-specific intervention, metabolite analysis, and transcriptomics provides a mechanistic framework for studying redox imbalance in osteoporosis.

• PP 2 (AG 1879) for Src Pathway Assays

  2026-08-28

  PP 2 (AG 1879) is a practical chemical probe for separating Src-family kinase signaling from downstream effects on proliferation, invasion, immunity, and cytoskeletal remodeling. This workflow-focused guide shows how to handle the compound, build interpretable dose responses, and extend Src assays into PA-Src-FAK-RhoA/ROCK research.

458 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page